top of page

THE HESS LAB

HEAL THYSELF: DEVELOPING REGENERATIVE THERAPIES FOR DIABETES AND ITS CARDIOVASCULAR COMPLICATIONS

The human body possesses tremendous capacity to heal itself! Tissue specific stem cells are found within every organ and possess the capacity to replace damaged cells or secrete signals that coordinate complex tissue repair and regenerative processes. 

 

We envision stem cells as ‘conductors of the orchestra’ that direct the myriad of cells and events involved in the regenerative response. However, during chronic diseases such as diabetes, relentless damage exhausts the stem cell pool, leading to progressive disability due to the development of cardiovascular disease. 

 

In the Hess laboratory, we aim to understand the mechanisms by which distinct stem cell coordinate islet and blood vessel regeneration. The overarching goal of our research program is the use of post-natal stem cells for the development of new and improved therapies for diabetes and its related cardiovascular complications.

 

​

We specialize in isolating and studying various stem cell lineages, including hematopoietic, endothelial, and mesenchymal cells. Through high-speed fluorescence-activated cell sorting and a deep understanding of conserved stem cell functions, we are expanding the boundaries of what is possible in regenerative medicine. 

OUR WORK

Our multidisciplinary research program addresses several barriers in the field of regenerative medicine for diabetes:

To generate stem cell-based biotherapeutics that suppress autoimmunity and stimulate islet formation.

To develop translational bioengineering technologies that promote the survival/regenerative function of transplanted stem cell lineages required for blood vessel regeneration.

To discover novel pharmaceutical agents for the reversal of vascular regenerative stem cell exhaustion in individuals with diabetes.

Harnessing the power of stem cells for islet and blood vessel regeneration, we strive to improve the health and longevity of individuals living with diabetes.

CURRENT PROJECTS

This section provides an overview of our current projects. Please note that some of these initiatives are collaborative efforts involving researchers not only at Western University but also at The University of Toronto. We believe in the power of teamwork and interdisciplinary cooperation to drive innovation in stem cell research.

7.png

Islet regeneration and replacement strategies

These projects aim to restore beta cell function and recapitulate insulin homeostasis in diabetic mouse models. Strategies include the use of mesenchymal stem cell (MSC)-secreted proteins to stimulate islet regeneration in situ and using lineage tracing to determine the mechanisms of regeneration. We are also elucidating the effects of MSC-secreted proteins on hESC-derived pancreatic progenitor cell differentiation and function.

endovascular-surgery-1600x732.jpeg

Bioengineering blood vessels

In collaboration with bioengineer Lauren Flynn, we seek to characterize the ability of human decellularized adipose tissue hydrogels to (1) act as a culture platform to support the pro-angiogenic function of MSC and endothelial colony forming cells in co-culture, and (2) improve cell survival and retention and hindlimb reperfusion following implantation in vivo.

beta-cells-1000x600.jpeg

Vascular regenerative cell exhaustion 

We have developed a novel flow cytometry assay to quantify vascular regenerative cell content based on the detection of circulating
progenitor cell subsets with high aldehyde dehydrogenase-activity. Using this unique platform, we have established that people with T2D and/or obesity exhibit the depletion and dysfunction of ALDHhi progenitor cells and monocytes with vessel regenerative function. We refer to this imbalance as vascular regenerative cell exhaustion. 

NEW!!

Discovery and validation of islet regenerative proteins secreted by human multipotent stromal cells. (2026)

Xin Y Xie , Nouran N Al-Banaa , Yina Tian , Gillian I Bell , Miljan Kuljanin , Tyler T Cooper , Caleb J Podgers , Ajaya Sharma , Anargyros Xenocostas , Gilles A Lajoie , David A Hess.  

 

Therapeutic Activities of Multipotent Stromal Cells for Islet Regeneration. (2026)

Nazihah Rasiwala, Gillian I Bell, Nouran N Al-Banaa, David A Hess.  ​

​

Icosapent ethyl modulates circulating vascular regenerative cell content: The IPE-PREVENTION CardioLink-14 trial (2024)

Ehab Bakbak, Aishwarya Krishnaraj, Deepak L Bhatt, Adrian Quan, Brady Park, Asaad I Bakbak, Basel Bari, Kristin A Terenzi, Yi Pan, Elizabeth J Fry, Daniella C Terenzi, Pankaj Puar, Tayyab S Khan, Ori D Rotstein, C David Mazer Lawrence A Leiter, Hwee Teoh, David A Hess, Subodh Verma  

​

Vascular Regenerative Cell Deficiencies in South Asian Adults. (2024)

Aishwarya Krishnaraj, Ehab Bakbak, Hwee Teoh, Yi Pan, Irene N. Firoz, Arjun K. Pandey, Daniella C. Terenzi, Raj Verma, Basel Bari, Asaad I. Bakbak, Shakkeela Padanilathu Kunjummar, Bobby Yanagawa, Kim A. Connelly, C. David Mazer, Ori D. Rotstein, Adrian Quan, Deepak L. Bhatt, Darren K. McGuire, David A. Hess, and Subodh Verma. (2024) Journal of the American College of Cardiology 83(7): 755–769.

       As featured in CBC 

 

Bone marrow–derived stem cells initiate pancreatic regeneration. (2003)

Hess D, Li L, Martin M, Sakano S, Hill D, Strutt B, Thyssen S, Gray DA, and Bhatia M. Bone marrow-derived stem cells initiate pancreatic regeneration. (2003) Nature Biotechnology 21(7): 763-770. 

​​

​

SGLT2 inhibition with empagliflozin increases circulating provascular progenitor cells in people with type 2 diabetes mellitus. (2019)

Hess DA, Terenzi DC, Trac JZ, Quan A, Mason T, Al-Omran M, Bhatt DL, Dhingra N, Rotstein OD, Leiter LA, Zinman B, Sabongui S, Yan AT, Teoh H, Mazer CD, Connelly KA, Verma S. SGLT2 inhibition with empagliflozin increases circulating provascular progenitor cells in people with type 2 diabetes mellitus. (2019) Cell Metabolism, 30(4):609-613.​

​

Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. (2004)

Hess DA, Meyerrose TE, Wirthlin L, Craft TP, Herrbrich PE, Creer MH, Nolta JA. Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. (2004) Blood 104(6): 1648-1655.

​

Cell therapy for critical limb ischemia: An integrated review of preclinical and clinical studies. (2018)

Qadura M, Terenzi DC, Verma S, Al-Omran M, Hess DA. Cell therapy for critical limb ischemia: An integrated review of preclinical and clinical studies. (2018) Stem Cells, 36(2):161-171.

​

Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells. (2006)

Hess DA, Wirthlin L, Craft TP, Herrbrich PE, Hohm SA, Lahey R, Eades WC, Creer MH, Nolta JA. Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells. (2006) Blood 107(5): 2162-2169.

​

Vascular repair and regeneration in cardiometabolic diseases. (2022)

Hess DA, Verma S, Bhatt D, Bakbak E, Terenzi DC, Puar P, Cosentino F. Vascular repair and regeneration in cardiometabolic diseases. (2022) European Heart Journal 43(6): 450-459.

​

​

PUBLICATIONS

Lecture hall seats

 COURSES

4520B at UWO, undergraduate

Stem Cell Biology and Regenerative Medicine

​

Coordinated and managed by Dr. Hess, this course explores fundamental concepts in regenerative medicine, including stem cell biology, and focuses on the physiology and pathophysiology of hematopoiesis and cancer development, blood vessel formation for tissue repair, and cellular transplantation for regenerative therapies.

4985 at UWO, undergraduate

Seminar and Research Project (4th year thesis)

A major laboratory project in Physiology or Pharmacology, which emphasizes experimental design, instrumentation, collection and analysis of data and communication of experimental results by oral, poster and written presentations. Students will select the physiology or pharmacology project from a list provided by the department and be matched to a supervisor.

9553 at UWO, graduate

Translational Research (Bench to Bedside)

Dr. Hess is a regular lecturer for this course. The objective of this course is to familiarize students with the approaches and issues associated with taking a basic science discovery through to effective therapeutic use in patient populations.  An additional objective is to expand the scope of students' understanding of how their graduate research project fits into the ‘bigger picture' of the advancement of science and medicine. 

TEAM

Our Current Lab Members

image_edited_edited.jpg

Principal Investigator

David A. Hess

Sheldon H. Weinstein Chair in Diabetes Research, Schulich School of Medicine

Scientist, Molecular Medicine Research Labs, Robarts Research Institute

Professor, Physiology & Pharmacology, Western University

Adjunct Professor, Pharmacology & Toxicology, University of Toronto

PhD Pharmacology & Toxicology, Western University

dhess@robarts.ca

dhess3@uwo.ca

519.931.5777 x. 24118

image.png

Research Associate

Gillian I. Bell

MSc Physiology, Western University

A17E3723-6030-412B-94C9-4EF35F9CFACA.JPEG

PhD Candidate

Nouran Al-Banaa

BMSc Interdisciplinary Medical Sciences, Western University

Project: Modulation of the human multipotent stromal cell secretome to attenuate hyperglycemia and insulitis in autoimmune diabetes

11DEDAA7-3CC0-41C7-AEF8-07D4A0395D92_edited.jpg

MSc Student

Caleb Podgers

BSc Kinesiology, Western University

Project: The effects of elevated Lipoprotein(a) on bone-marrow derived vascular regenerative cells.

C6F9628B-D491-45E1-89E3-10A62F7B7D0F_1_105_c.jpeg

PhD Candidate at UofT (co-supervised by Dr. Subodh Verma)

Fallon Dennis

BMSc Physiology & Pharmacology, Western University

Project: Functional consequences of vascular regenerative cell exhaustion during type 2 diabetes

1723903203672.jpeg

PhD Candidate at UofT (co-supervised by Dr. Subodh Verma)

Cole Dennis

MASc Biomedical Engineering, McMaster University

BASc Biomedical Sciences, Trent University

Screenshot 2025-12-12 at 9.52.24 AM.png

MD/PhD Candidate at UofT (co-supervised by Dr. Subodh Verma)

Braeden Hill

BHSc, Queen's University

Project: Vascular regenerative cell exhaustion

IMG_5233_edited.jpg

Undergraduate Student

Amrita Dudaka

2nd Year Medical Sciences Student

​

image.png

PhD candidate (Pretty happy Dog)

Willow

Master of digging holes

Project: Digging holes

Former Trainees

David Putman

PhD Physiology & Pharmacology
MD University of Toronto

Ayesh Seneviratne

MSc Physiology & Pharmacology
MD/PhD at University of Toronto
​

Miljan Kuljanin

PhD Biocheistry (co-supervised by Dr. Gilles Lajoie)
PDF at Harvard University

Joban Dhillon

MSc Physiology & Pharmacology (co-supervised by Dr. Lauren Flynn)
MD McGill University

Ahmed Shah

MSc Physiology & Pharmacology
(co-supervised by Dr. Cheryle Seguin)
MD University of Toronto
​

Stephen Sherman

PhD Physiology & Pharmacology
PDF at Harvard University
​
​

Tyler Cooper

PhD Physiology & Pharmacology
PDF at Western University
​
​

Ruth Elgamal

MSc Physiology & Pharmacology
PhD candidate at the University of California, San Diego

Chris LeClerc

MEng Biomedical Engineering
(co-supervised by Dr. Lauren Flynn)
​

Yehia Moharrem

MSc Physiology & Pharmacology,
MD Candidate at Western University

Brianna Ananthan

MSc Physiology & Pharmacology
MD Candidate at Western University

Nazihah Rasiwala

MSc Physiology & Pharmacology

Justin Trac

MSc Pharmacology & Toxicology, University of Toronto
DDS at UofT

Daniella Terenzi

PhD Integrated Medical Sciences, University of Toronto
MD at University College Dublin
MSc Physiology & Pharmacology,
MD Candidate at Western University

Ehab Bakbak

PhD (co-supervised by Dr. Subodh Verma at UofT)
MD Candidate at University of Queensland

Yina Tian

MSc Physiology & Pharmacology
MD Candidate at Queen's University

Brady Park

PhD Physiology & Toxicology
MD Candidate at University of Toronto

Agnes Terek

MSc Physiology & Pharmacology (co-supervised by Dr. Lauren Flynn),
MD Candidate at McMaster University

Sarah From

MESc Biomedical Engineering (co-supervised by Dr. Lauren Flynn)

Xin Yue (Sharon) Xie

bottom of page